28.06.2018 08:00:43
|
Interim report September 1, 2017 - May 31, 2018
Company announcement no.11/2018
Report attached
For further information, please contact:
Martin Riise, Head of Investor Relations
Tel: +45 53 39 22 50
Helle Rexen, Interim Head of Media Relations
Tel: +45 20 74 28 40
About Chr. Hansen
Chr. Hansen is a leading global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. We develop and produce cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed and plant protection. Our product innovation is based on more than 30,000 microbial strains – we like to refer to them as "good bacteria.” Our solutions enable food manufacturers to produce more with less – while also reducing the use of chemicals and other synthetic additives – which makes our products highly relevant in today’s world. We have been delivering value to our partners – and, ultimately, end consumers worldwide – for more than 140 years. We are proud that more than 1 billion people consume products containing our natural ingredients every day.
Attachment
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Chr. Hansen Holding A-Smehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Chr. Hansen Holding A-Smehr Analysen
Aktien in diesem Artikel
Chr. Hansen Holding A-S | 73,64 | 28,25% |